secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001040130-25-000074
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express FY2025 net sales $227M, net loss $6.3M; Q1/Q2 filings delayed
----------------------------------------------------------------------------

- Net sales of $227.0M for FY2025 below preliminary range of $231.6M-$233.6M due to restatement of promotional sales reimbursements to cost of sales.
- Net loss of $6.3M widened from preliminary estimated loss of $4.5M-$5.0M, driven by a $1.2M non-cash impairment charge for intangible assets.
- Cash balance of $54.7M and no debt as of March 31, 2025.
- Company filed Form 10-K; plans to file Q1 and Q2 2025 reports and resume normal quarterly earnings call cadence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/0001040130-25-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/pets-20251014.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer